| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Platelet dysfunction caused by aspirin (disorder) |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Esophageal ulcer caused by aspirin |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin-sensitive asthma with nasal polyps |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin burn of oral mucosa |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Non-allergic anaphylaxis caused by aspirin |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin-induced angioedema-urticaria (disorder) |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Intentional aspirin overdose (disorder) |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylate blood measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Serum salicylate measurement (procedure) |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Administration of prophylactic aspirin for ischemic heart disease (procedure) |
Direct substance |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Acetylsalicylic acid measurement, qualitative |
Component |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental aspirin poisoning |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional aspirin poisoning |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin adverse reaction |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to aspirin |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin overdose |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental aspirin overdose |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin overdose of undetermined intent |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of prophylactic aspirin |
Direct substance |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Plasma salicylate measurement (procedure) |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 75 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 75mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300mg e/c tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 150 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 500mg soluble tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin/paracetamol/codeine tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + codeine 400mg/8mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin+papaveretum 500mg/7.71mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin+papaveretum 500mg/10mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 300mg dispersible tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ulcer of esophagus caused by ingestion of aspirin |
Causative agent (attribute) |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-codaprin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 500 mg and glycine 133 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin+codeine 300mg/8mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aspirin in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Aspirin compound preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral aspirin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salicylate measurement |
Component |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 81 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 227.5mg gum tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 81mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 650mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 975mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 650mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 800mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 81mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 120 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 600mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 975 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg and carisoprodol 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg and meprobamate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg and methocarbamol 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + pentazocine hydrochloride 325mg/ns tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 975mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin 500 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspirin + caffeine + orphenadrine citrate tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ecotrin tablets and caplets 325mg e/c tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Regular strength bayer enteric coated 325mg caplets (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Genuine bayer aspirin 325mg tablets and caplets (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Empirin 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Genprin 325mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ecotrin maximum strength 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Extra strength bayer enteric 500 aspirin 500mg e/c tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Arthritis foundation pain reliever 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Maximum bayer aspirin 500mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Norwich extra strength 500mg tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Extended release bayer 8 hour 650mg er tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ecotrin adult low strength 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Halfprin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Heartline 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| 1/2 Halfprin 165mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bayer low adult strength 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Bayer children's aspirin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| St. Joseph adult chewable aspirin 81mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aspergum 227.5mg gum tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]